{"disease":{"id":"irritable-bowel-syndrome-with-constipation-ibs-c","name":"irritable bowel syndrome with constipation ibs c"},"drugs":{"marketed":[{"drug_id":"tenapanor","indication_name":"Irritable Bowel Syndrome with Constipation (IBS-C)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"TENAPANOR","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":30,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":1,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03471728","title":"Post-marketing Surveillance of Linaclotide Tablet in Patients With Irritable Bowel Syndrome With Constipation or Chronic Constipation (Excluding Constipation Due to Organic Diseases)","phase":"","overall_status":"COMPLETED","enrollment_count":2475,"lead_sponsor_name":"Astellas Pharma Inc","has_results":false},{"nct_id":"NCT02316899","title":"Phase III Study to Evaluate the Efficacy and Safety of ASP0456 in Patients With Constipation Predominant Irritable Bowel Syndrome","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":500,"lead_sponsor_name":"Astellas Pharma Inc","has_results":false},{"nct_id":"NCT05643534","title":"Study to Assess Safety and Efficacy of Tenapanor for Treatment of IBS-C in Pediatric Patients 12 to Less Than 18 Years","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":180,"lead_sponsor_name":"Ardelyx","has_results":false},{"nct_id":"NCT05240521","title":"Efficacy and Safety, Tolerability of GA-AT0119 in IBS-C","phase":"NA","overall_status":"UNKNOWN","enrollment_count":60,"lead_sponsor_name":"Devintec Sagl","has_results":false}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}